Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma. Methods: HIV‐based lentiviral vectors were pseudotyped with four different envelope proteins; amphotropic murine leukaemia virus (ampho), murine leukaemia virus (10A1), feline endogenous virus (RD114), and the vesicular stomatitis virus glycoprotein (VSVG). These pseudotypes were examined for transduction efficiency in human bone marrow derived MSC. The effect of lentiviral expression of truncated soluble vascular endothelial growth factor decoy receptor (tsFlk‐1) in MSC on growth of Raji cells was determined, both in vitro and in vivo. Results: All lentiviral vectors produced significant levels of transduction at an multiplicity of infection (MOI) of 1, those bearing the RD114 envelope glycoprotein consistently produced higher transduction levels (mean 70 ± 6%) compared with the other pseudotyped lentiviral vectors, although there was significant inter‐donor variation. Stable transgene expression was achieved after multiple rounds of transduction with VSVG‐pseudotyped particles, without alteration in the differentiative capacity of transduced cells. Co‐injection of MSC stably expressing tsFlk‐1 with Raji Burkitt's lymphoma cells significantly impaired subcutaneous tumour growth in immunodeficient mice when compared to controls where either unmanipulated MSC or GFP‐expressing MSC were used. Conclusions: Human MSC are easily transduced by pseudotyped lentiviral particles but there is inter‐donor variation in transduction efficiency. Gene‐modified MSC expressing a gene of therapeutic potential can moderate growth of haematological malignancies. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., & Yee, J. K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8033 · Cited by 1,399
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
Robinson, C. J., & Stringer, S. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.853 · Cited by 944
Research works printed but not linked: 33
- 10.1634/stemcells.20-3-205 · DOI · Paper page
- 10.1038/sj.thj.6200232 · DOI · Paper page
- 10.1073/pnas.1834138100 · DOI · Paper page
- 10.1161/hc0102.101442 · DOI · Paper page
- 10.1067/mtc.2000.110250 · DOI · Paper page
- Choi YS, 2003, A workshop on the marrow microenvironment and hematological malignancy, Cancer Res, 63, 7539
- 10.1016/S1470-2045(03)01195-1 · DOI
- 10.1080/10428190210188 · DOI
- 10.1080/14653240310000092 · DOI
- Ribatti D, 2001, Angiogenesis, angiogenic factor expression and hematological malignancies, Anticancer Res, 21, 4333
- 10.1182/blood-2002-06-1830 · DOI · Paper page
- 10.1038/6529 · DOI · Paper page
- 10.1016/S0301-472X(00)00482-3 · DOI · Paper page
- 10.1038/sj.gt.3302071 · DOI · Paper page
- 10.1080/14653240310001299 · doi:10.1080/14653240310001299
- Naldini L, 1999, In vivo gene delivery by lentiviral vectors, Thromb Haemost, 82, 552, 10.1055/s-0037-1615879 · doi:10.1055/s-0037-1615879
- 10.1126/science.283.5402.682 · DOI · Paper page
- 10.1046/j.1365-2141.2002.03561.x · doi:10.1046/j.1365-2141.2002.03561.x
- 10.1182/blood-2003-06-1770 · DOI
- 10.1006/mthe.2002.0549 · DOI · Paper page
- Davidoff AM, 2002, rAAV‐mediated long‐term liver‐generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice, Cancer Res, 62, 3077
- 10.1128/JVI.78.3.1219-1229.2004 · DOI
- 10.1089/10430349950018157 · DOI · Paper page
- 10.1006/mthe.2002.0585 · DOI · Paper page
- 10.1038/nm0603-669 · DOI · Paper page
- 10.1007/s005990050018 · DOI
- 10.1016/S0301-472X(03)00159-0 · DOI
- Bachelder RE, 2001, Vascular endothelial growth factor is an autocrine survival factor for neuropilin‐expressing breast carcinoma cells, Cancer Res, 61, 5736
- 10.1016/S0092-8674(02)01229-1 · DOI · Paper page
- 10.1006/scbi.2000.0361 · DOI · Paper page
- Studeny M, 2003, Bone marrow‐derived mesenchymal stem cells as vehicles for interferon‐b delivery into tumors, Cancer Res, 62, 3603
- 10.1126/science.291.5503.447 · DOI · Paper page
- 10.1111/j.1749-6632.2003.tb03239.x · DOI
Cited by
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
Mesenchymal stem cells: a new strategy for immunosuppression?
Uccelli, A., Pistoia, V., & Moretta, L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.001 · Cited by 461
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Loebinger, M. R., Eddaoudi, A., Davies, D., & Janes, S. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4698 · Cited by 417
“Furthermore, they have the ability to stably transduce both dividing and quiescent cells (29), which is a further significant advantage when using stem cells that are often quiescent or slowgrowing.”
BackgroundMesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration
Kode, J. A., Mukherjee, S., Joglekar, M. V., & Hardikar, A. A. (2009) · Cytotherapy · doi:10.1080/14653240903080367 · Cited by 384
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Metadata
- Authors
- Kyriakou, C. A., Yong, K. L., Benjamin, R., Pizzey, A., Dogan, A., Singh, N., Davidoff, A. M., & Nathwani, A. C.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2005-11-16
- Volume
- 8
- Issue
- 3
- Pages
- 253-264
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2093817631
- Cited by
- 50
- References
- 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.